Kenya BioVax Institute Limited

Home » Ministries » Ministry of Health » State Department For Public Health and Professional Standards » Kenya BioVax Institute Limited

Overview

website
info@biovax.go.ke

The Kenya BioVax Institute Limited, formed under the Companies Act of 2015, is dedicated to enhancing local vaccine production and biotherapeutics. Its primary roles include the development and manufacturing of vaccines, ensuring adherence to international
quality standards, conducting research and innovation in immunization, and fostering partnerships with global health organizations. The institute aims to bolster Kenya’s self-reliance in healthcare, particularly in response to pandemics, thereby improving access to essential vaccines and enhancing national public health security.

CEO: Dr. Michael Lusiola

Dr. Michael Lusiola holds a Doctorate and Masters degrees in Evidence-based Medicine, Pharmacotherapeutics and Business Administration. He has post graduate diplomas in Management, in Global Health and in Clinical Pharmacology. He has over 23 years experience working in global pharmaceutical research and development, and in clinical practice in the UK and USA.

Management Team

Dr. Michael Lusiola

Chief Executive Officer

Dr. Cecilia Wanjala

General Manager Commercial Services

Dr. Serah Muteru

General Manager Regulatory Affairs, Product Quality Assurance & Safety

Col. Robert Gatata

Head of Facility Readiness, ICT and Security

Lucas Ouma

Manager, Supply Chain Management

Chris Muindi

Manager, ICT & Security

Dr. Rabera Kenyanya

Head of Technical Operations

Solomon Aswani

Head of Finance & Accounts

Lai Clare

Head Legal & Board Affairs

Board of Governors

Mugo Kibati

Chairman

Sachen Chandaria

Director

Shamim Chanzu

Director

Dr. Dennis Rangi

Director

Dr. John Kiiru

Alternate to PS, Ministry of Health

Cheryl Majiwa

Alternate to PS, National Treasury and Planning

Edwin Bett

Director (Alternate to Director General KEMRI)

Dr. Michael Lusiola

Chief Executive Officer

Functions

  • Vaccine Development – Conduct research and development for new vaccines tailored to local health needs.
  • Manufacturing and Production – Establish manufacturing capabilities for vaccines and biotherapeutics to ensure local availability.
  • Quality Assurance- Ensure that all products meet international quality and safety standards.
  • Research and Innovation – Promote innovative practices in vaccine technology and biomanufacturing.
  • Collaboration with Health Bodies – Partner with national and international health organizations for knowledge exchange and technical support.
  • Public Health Response – Enhance the country’s capacity to respond to public health emergencies, including pandemics.
  • Training and Capacity Building – Provide training for healthcare professionals in vaccine development and administration.
  • Community Engagement – Educate the public on the importance of vaccines and immunization programs.
  • Policy Development – Contribute to health policy formulation regarding immunization and vaccine deployment.
  • Sustainability Initiatives – Implement sustainable practices in vaccine production to ensure environmental responsibility​

Important Links

Address & Contacts

  • BioVax Institute, Nairobi, Kenya
  • P.O. Box 40779-00100 Nairobi
  • info@biovax.go.ke
  • +254775751639